Applied DNA Sciences, Inc. (NASDAQ:APDN) Files An 8-K Regulation FD Disclosure

Applied DNA Sciences, Inc. (NASDAQ:APDN) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

On October 1, 2019, Applied DNA Sciences, Inc. (the “Company”) received written notice from the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC (the “Panel”) indicating that the Panel has granted the Company’s request for the continued listing of the Company’s securities on The Nasdaq Capital Market (“Nasdaq”), subject to the Company evidencing compliance on or before December 31, 2019 with both the minimum $1.00 bid price and that it has at least $2.5 million in stockholders’ equity, as set forth in Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), respectively. During this time, the Company’s securities will remain listed and trading on Nasdaq.

In addition, on October 3, 2019, the Company issued a press release with regard to the written notice it received from the Panel. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information related to the press release furnished to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

99.1 Press Release of Applied DNA Sciences, Inc. dated October 3, 2019.

EX-99.1 2 tv530575_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1       Applied DNA Receives Extension from Nasdaq   STONY BROOK,…
To view the full exhibit click here

Story continues below

About Applied DNA Sciences, Inc. (NASDAQ:APDN)

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company’s platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.

An ad to help with our costs